Biomedical subjects

Marco Foracchia

Publications and source records attributed to Marco Foracchia.

3 recordsLinked to original sources

PubMed2005

Luminosity and contrast normalization in retinal images.

Retinal images are routinely acquired and assessed to provide diagnostic evidence for many important diseases, e.g. diabetes or hypertension. Because of the acquisition process, very often these images are non-uniformly illuminated and exhibit local luminosity and contrast variability. This problem may seriously affect the diagnostic process and its outcome, especially if an automatic computer-based procedure is used to derive diagnostic parameters. We propose here a new method to normalize luminosity and contrast in retinal images, both intra- and inter-image. The method is based on the estimation of the luminosity and contrast variability in the background part of the image and the subsequent compensation of this variability in the whole image. The application of this method on 33 fundus images showed an average 19% (max. 45%) reduction of luminosity variability and an average 34% (max. 85%) increment of image contrast, with a remarkable improvement, e.g., over low-pass correction. The proposed image normalization technique will definitely improve automatic fundus images analysis but will also be very useful to eye specialists in their visual examination of retinal images.

Fluorescein Angiography↗

PubMed2004

POPED, a software for optimal experiment design in population kinetics.

Population kinetic analysis is the methodology used to quantify inter-subject variability in kinetic studies. It entails the collection of (possibly sparse) data from dynamic experiments in a group of subjects and their quantitative interpretation by means of a mathematical model. This methodology is widely used in the pharmaceutical industry (where it is termed "pharmacokinetic population analysis") and recently it is becoming increasingly used in other areas of biomedical research. Unlike traditional kinetic studies, where the number of subjects can be quite small, population kinetic studies require large numbers of subjects. It is, therefore, of great interest to design these studies in the most efficient manner possible, to maximize the information content provided by the data. In this paper we propose an algorithm and a computer program, POPED, for the optimal design of a population kinetic experiment. In particular, the number of samples for each subject and the design of the individual sampling strategies, i.e. the number and location of the time points at which the output variable is sampled, will be considered. Among the various criteria proposed in the literature, D and ED optimality are the ones implemented in our software program, since they are the most widely used. A brief description of the techniques employed to perform design optimization is given, together with some details on their actual implementation. Some examples are then presented to show the program usage and the results provided.

Algorithms↗

PubMed2003

An evaluation of population D-optimal designs via pharmacokinetic simulations.

One goal of large scale clinical trials is to determine how a drug is processed by, and cleared from, the human body [i.e., its pharmacokinetic (PK) properties] and how these PK properties differ between individuals in a population (i.e., its population PK properties). Due to the high cost of these studies and the limited amount of data (e.g., blood samples) available from each study subject, it would be useful to know how many measurements are needed and when those measurements should be taken to accurately quantify population PK model parameters means and variances. Previous studies have looked at optimal design strategies of population PK experiments by developing an optimal design for an individual study (i.e., no interindividual variability was considered in the design), and then applying that design to each individual in a population study (where interindividual variability is present). A more algorithmically and informationally intensive approach is to develop a population optimal design, which inherently includes the assessment of interindividual variability. We present a simulation-based evaluation of these two design methods based on nonlinear Gaussian population PK models. Specifically, we compute standard individual and population D-optimal designs and compare population PK model parameter estimates based on simulated optimal design measurements. Our results show that population and standard D-optimal designs are not significantly different when both designs have the same number of samples per individual. However, population optimal designs allow for sampling schedules where the number of samples per individual is less than the number of model parameters, the theoretical limit allowed in standard optimal design. These designs with a low number of samples per individual are shown to be nearly as robust in parameter estimation as standard D-optimal designs. In the limit of just one sample per individual, however, population D-optimal designs are shown to be inadequate.

AIDS Vaccines↗